Genome-wide association study for germline prognostic markers in colorectal cancer

Genome-wide association study for germline prognostic markers in colorectal cancer

Podrobná bibliografie
Hlavní autoři:	Walther, A, Domingo, E, Mesher, D, Johnstone, E, Orntoft, T, Sasieni, P, Dunlop, M, Tejpar, S, Kerr, D, Tomlinson, I, Grp, V, Grp, P
Médium:	Journal article
Vydáno:	2010

Podobné jednotky

Genetic prognostic and predictive markers in colorectal cancer.
Autor: Walther, A, a další
Vydáno: (2009)

Erratum: Genetic prognostic and predictive markers in colorectal cancer (Nature Reviews Cancer (2009) 9 (489-499))
Autor: Walther, A, a další
Vydáno: (2011)

Effect of SNP haplotypes associated with colorectal cancer risk on outcome
Autor: Walther, A, a další
Vydáno: (2008)

Is sidedness prognostically important across all stages of colorectal cancer?
Autor: Kerr, D, a další
Vydáno: (2016)

Genetic prognostic markers in colorectal cancer.
Autor: Houlston, R, a další
Vydáno: (1997)

What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer?
Autor: Johnstone, E, a další
Vydáno: (2008)

REporting recommendations for tumor MARKer prognostic studies (REMARK)
Autor: McShane, L, a další
Vydáno: (2005)

REporting recommendations for tumor MARKer prognostic studies (REMARK)
Autor: McShane, L, a další
Vydáno: (2005)

Genome wide identification of novel DNA methylation driven prognostic markers in colorectal cancer
Autor: Yuhua Ma, a další
Vydáno: (2024-07-01)

Germline epimutations of APC are not associated with inherited colorectal polyposis.
Autor: Hitchins, M, a další
Vydáno: (2006)

VICTOR: A PHASE III PLACEBO-CONTROLLED TRIAL OF ROFECOXIB IN COLORECTAL CANCER PATIENTS FOLLOWING SURGICAL RESECTION
Autor: Midgley, R, a další
Vydáno: (2008)

Follow up after colorectal surgery (the FACS trial)
Autor: Corkhill, A, a další
Vydáno: (2004)

EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis
Autor: Kokko, A, a další
Vydáno: (2006)

Mutation burden and other molecular markers of prognosis in the QUASAR2 clinical trial of colorectal cancer treated with curative intent
Autor: Domingo, E, a další
Vydáno: (2018)

Germline genetic regulation of the colorectal tumor immune microenvironment
Autor: Stephanie L. Schmit, a další
Vydáno: (2024-04-01)

Germline HNPCC gene variants have little influence on the risk for sporadic colorectal cancer.
Autor: Tomlinson, I, a další
Vydáno: (1997)

GLR in Colorectal Cancers: An Easily Accessible Prognostic Marker
Autor: Aydin İC, a další
Vydáno: (2024-05-01)

Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer
Autor: Houlston, R, a další
Vydáno: (2008)

Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer.
Autor: Houlston, R, a další
Vydáno: (2008)

Frequency of germline hereditary non-polyposis colorectal cancer gene mutations in patients with multiple or early onset colorectal adenomas.
Autor: Beck, N, a další
Vydáno: (1997)

Germline and somatic polymerase ε and δ mutations define a new class of hypermutated colorectal and endometrial cancers.
Autor: Briggs, S, a další
Vydáno: (2013)

Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.
Autor: Palles, C, a další
Vydáno: (2013)

Genome-wide association study of germline variants and breast cancer-specific mortality
Autor: Escala-Garcia, M, a další
Vydáno: (2019)

QUASAR: A randomized study of adjuvant chemotherapy (CT) vs observation including 3238 colorectal cancer patients.
Autor: Gray, R, a další
Vydáno: (2004)

Prognostic value of p53, hMLH1, hMSH2, MGMT and COX-2 in the QUASAR-1 Dukes' stage B colorectal cancer cohort
Autor: Jubb, A, a další
Vydáno: (2002)

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
Autor: Kerr, R, a další
Vydáno: (2016)

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
Autor: Love, S, a další
Vydáno: (2016)

A detector for precision study of high energy e(+)e(-) annihilations: The ECFA/DESY design for TESLA
Autor: Burrows, P, a další
Vydáno: (2000)

Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer.
Autor: Domingo, E, a další
Vydáno: (2013)

Germline determinants of colorectal cancer risk and outcome
Autor: Freeman-Mills, L
Vydáno: (2017)

MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer.
Autor: Hitchins, M, a další
Vydáno: (2005)

Germline epigenetic silencing of the tumor suppressor gene PTPRJ in early-onset familial colorectal cancer.
Autor: Venkatachalam, R, a další
Vydáno: (2010)

Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer
Autor: Teo, M, a další
Vydáno: (2014)

Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers.
Autor: Halford, SE, a další
Vydáno: (2003)

Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
Autor: Domingo, E, a další
Vydáno: (2018)

A genome-wide scan of 10 000 gene-centric variants and colorectal cancer risk.
Autor: Webb, E, a další
Vydáno: (2009)

Germline deletions of EXO1 do not cause colorectal tumors and lesions which are null for EXO1 do not have microsatellite instability.
Autor: Alam, N, a další
Vydáno: (2003)

Genome-wide allelotyping of 104 Finnish colorectal cancers reveals an excess of allelic imbalance in chromosome 20q in familial cases.
Autor: Laiho, P, a další
Vydáno: (2003)

Comprehensive assessment of variation at the transforming growth factor beta type 1 receptor locus and colorectal cancer predisposition.
Autor: Carvajal-Carmona, L, a další
Vydáno: (2010)

PROGNOSTIC MARKERS FOR THROMBOTIC EVENTS IN PATIENTS WITH GASTRIC OR COLORECTAL ADENOCARCINOMAS
Autor: Emilly de Assis MACHADO, a další
Vydáno: (2024-12-01)